Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TOP-M119
- Development stage
- Preclinical
- Lead developer
- Topadur Pharma
- Modality
- Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical, Transdermal, Intradermal
01
Overview
TOP-M119 is a novel small molecule drug candidate developed for the treatment of alopecia, including androgenic alopecia and chemotherapy-induced hair loss. It acts as a dual-mode vasodilator by activating the cGMP-enzyme regulatory system, thereby increasing blood flow to hair follicles and supporting hair regrowth. Preclinical studies have demonstrated that TOP-M119 is significantly more potent than standard treatments such as minoxidil, with a faster onset of action and improved local tolerability. The drug has been formulated for topical application and can also be delivered via dissolving microneedle systems to enhance targeted delivery to hair follicles while minimizing systemic exposure. Development efforts are led by Topadur Pharma in collaboration with Oshen Holdings, focusing on both liquid topical formulations and intradermal sustained release systems.
- Other names
- M119M-119M 119
Beyond the preview
Go deeper on TOP-M119.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TOP-M119.